335 related articles for article (PubMed ID: 33639165)
41. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
[TBL] [Abstract][Full Text] [Related]
42. Gallium maltolate has
Bernstein LR; Zhang L
Antivir Chem Chemother; 2020; 28():2040206620983780. PubMed ID: 33353394
[TBL] [Abstract][Full Text] [Related]
43. Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection.
Ciccosanti F; Di Rienzo M; Romagnoli A; Colavita F; Refolo G; Castilletti C; Agrati C; Brai A; Manetti F; Botta L; Capobianchi MR; Ippolito G; Piacentini M; Fimia GM
Antiviral Res; 2021 Jun; 190():105064. PubMed ID: 33781803
[TBL] [Abstract][Full Text] [Related]
44. Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta.
Fröba M; Große M; Setz C; Rauch P; Auth J; Spanaus L; Münch J; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Prieschl-Grassauer E; Grassauer A; Schubert U
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947999
[TBL] [Abstract][Full Text] [Related]
45. Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication.
Williams CG; Jureka AS; Silvas JA; Nicolini AM; Chvatal SA; Carlson-Stevermer J; Oki J; Holden K; Basler CF
Cell Rep; 2021 Aug; 36(5):109479. PubMed ID: 34320401
[TBL] [Abstract][Full Text] [Related]
46. The chemosensitizing activity of inhibitors of glucosylceramide synthase is mediated primarily through modulation of P-gp function.
Chai L; McLaren RP; Byrne A; Chuang WL; Huang Y; Dufault MR; Pacheco J; Madhiwalla S; Zhang X; Zhang M; Teicher BA; Carter K; Cheng SH; Leonard JP; Xiang Y; Vasconcelles M; Goldberg MA; Copeland DP; Klinger KW; Lillie J; Madden SL; Jiang YA
Int J Oncol; 2011 Mar; 38(3):701-11. PubMed ID: 21186402
[TBL] [Abstract][Full Text] [Related]
47. Methotrexate inhibits SARS-CoV-2 virus replication "in vitro".
Caruso A; Caccuri F; Bugatti A; Zani A; Vanoni M; Bonfanti P; Cazzaniga ME; Perno CF; Messa C; Alberghina L
J Med Virol; 2021 Mar; 93(3):1780-1785. PubMed ID: 32926453
[TBL] [Abstract][Full Text] [Related]
48. Antiviral Activity of the Propylamylatin
Brown AN; Strobel G; Hanrahan KC; Sears J
Viruses; 2021 Mar; 13(3):. PubMed ID: 33807769
[TBL] [Abstract][Full Text] [Related]
49. Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture.
Wang X; Sacramento CQ; Jockusch S; Chaves OA; Tao C; Fintelman-Rodrigues N; Chien M; Temerozo JR; Li X; Kumar S; Xie W; Patel DJ; Meyer C; Garzia A; Tuschl T; Bozza PT; Russo JJ; Souza TML; Ju J
Commun Biol; 2022 Feb; 5(1):154. PubMed ID: 35194144
[TBL] [Abstract][Full Text] [Related]
50. Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses.
Nguyen LC; Yang D; Nicolaescu V; Best TJ; Gula H; Saxena D; Gabbard JD; Chen SN; Ohtsuki T; Friesen JB; Drayman N; Mohamed A; Dann C; Silva D; Robinson-Mailman L; Valdespino A; Stock L; Suárez E; Jones KA; Azizi SA; Demarco JK; Severson WE; Anderson CD; Millis JM; Dickinson BC; Tay S; Oakes SA; Pauli GF; Palmer KE; ; Meltzer DO; Randall G; Rosner MR
Sci Adv; 2022 Feb; 8(8):eabi6110. PubMed ID: 35050692
[TBL] [Abstract][Full Text] [Related]
51. Genome-scale CRISPR screens identify host factors that promote human coronavirus infection.
Grodzki M; Bluhm AP; Schaefer M; Tagmount A; Russo M; Sobh A; Rafiee R; Vulpe CD; Karst SM; Norris MH
Genome Med; 2022 Jan; 14(1):10. PubMed ID: 35086559
[TBL] [Abstract][Full Text] [Related]
52. A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity.
Nittayananta W; Lerdsamran H; Chutiwitoonchai N; Promsong A; Srichana T; Netsomboon K; Prasertsopon J; Kerdto J
Virol J; 2024 Jan; 21(1):26. PubMed ID: 38263162
[TBL] [Abstract][Full Text] [Related]
53. Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro.
Ohashi H; Wang F; Stappenbeck F; Tsuchimoto K; Kobayashi C; Saso W; Kataoka M; Yamasaki M; Kuramochi K; Muramatsu M; Suzuki T; Sureau C; Takeda M; Wakita T; Parhami F; Watashi K
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808940
[TBL] [Abstract][Full Text] [Related]
54. Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease.
Fu L; Ye F; Feng Y; Yu F; Wang Q; Wu Y; Zhao C; Sun H; Huang B; Niu P; Song H; Shi Y; Li X; Tan W; Qi J; Gao GF
Nat Commun; 2020 Sep; 11(1):4417. PubMed ID: 32887884
[TBL] [Abstract][Full Text] [Related]
55. Comparison of Antiviral Activity of Gemcitabine with 2'-Fluoro-2'-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2.
Jang Y; Shin JS; Lee MK; Jung E; An T; Kim UI; Kim K; Kim M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557278
[TBL] [Abstract][Full Text] [Related]
56. Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors.
Huff S; Kummetha IR; Tiwari SK; Huante MB; Clark AE; Wang S; Bray W; Smith D; Carlin AF; Endsley M; Rana TM
J Med Chem; 2022 Feb; 65(4):2866-2879. PubMed ID: 34570513
[TBL] [Abstract][Full Text] [Related]
57. Long-chain polyphosphates impair SARS-CoV-2 infection and replication.
Ferrucci V; Kong DY; Asadzadeh F; Marrone L; Boccia A; Siciliano R; Criscuolo G; Anastasio C; Quarantelli F; Comegna M; Pisano I; Passariello M; Iacobucci I; Monica RD; Izzo B; Cerino P; Fusco G; Viscardi M; Brandi S; Pierri BM; Borriello G; Tiberio C; Atripaldi L; Bianchi M; Paolella G; Capoluongo E; Castaldo G; Chiariotti L; Monti M; De Lorenzo C; Yun KS; Pascarella S; Cheong JH; Kim HY; Zollo M
Sci Signal; 2021 Jul; 14(690):. PubMed ID: 34230209
[TBL] [Abstract][Full Text] [Related]
58.
Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
[TBL] [Abstract][Full Text] [Related]
59. The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines.
Luban J; Sattler RA; Mühlberger E; Graci JD; Cao L; Weetall M; Trotta C; Colacino JM; Bavari S; Strambio-De-Castillia C; Suder EL; Wang Y; Soloveva V; Cintron-Lue K; Naryshkin NA; Pykett M; Welch EM; O'Keefe K; Kong R; Goodwin E; Jacobson A; Paessler S; Peltz SW
Virus Res; 2021 Jan; 292():198246. PubMed ID: 33249060
[TBL] [Abstract][Full Text] [Related]
60. A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection.
Humphries F; Shmuel-Galia L; Jiang Z; Wilson R; Landis P; Ng SL; Parsi KM; Maehr R; Cruz J; Morales-Ramos A; Ramanjulu JM; Bertin J; Pesiridis GS; Fitzgerald KA
Sci Immunol; 2021 May; 6(59):. PubMed ID: 34010139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
